Silvers Daniel B. 13D and 13G filings for Ensysce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-07-07 09:08 am Unchanged |
2022-06-30 | 13D | Ensysce Biosciences, Inc. ENSC |
Silvers Daniel B. | 801 7.900% |
0 (Unchanged) |
Filing |
2021-10-12 4:15 pm Unchanged |
2021-10-07 | 13D | Ensysce Biosciences, Inc. ENSC |
Silvers Daniel B. | 801 11.080% |
0 (Unchanged) |
Filing |
2021-07-06 4:15 pm Purchase |
2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC |
Silvers Daniel B. | 801 11.080% |
801![]() (New Position) |
Filing |